Soc. Generale Knock-Out AZN/ DE000SD9JQM7 /
9/2/2024 12:23:02 PM | Chg.0.000 | Bid1:12:28 PM | Ask1:12:28 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
7.110EUR | 0.00% | 7.120 Bid Size: 10,000 |
7.130 Ask Size: 10,000 |
Astrazeneca PLC ORD ... | 72.871 GBP | 12/31/2078 | Call |
GlobeNewswire
8/12
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire
8/8
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire
8/6
FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
6/26
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire
6/18
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
6/18
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
6/13
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
5/8
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
5/2
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...